IMS
MYGN icon

Index Management Solutions’s Myriad Genetics MYGN Stock Holding History

Index Management Solutions’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-8,718
Closed -$336K – 920
2014
Q3 		$336K Sell
8,718
-3,126
-26% -$117K 0.04% 416
2014
Q2 		$461K Buy
11,844
+8,196
+225% +$305K 0.06% 281
2014
Q1 		$125K Buy
+3,648
New +$113K 0.02% 375

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Index Management Solutions's MYGN Position: Q4 2014 in Review

Index Management Solutions sold out of Myriad Genetics (MYGN) in Q4 2014, closing a stake of 8,718 shares — an estimated $336K sold.

Index Management Solutions first reported a position in MYGN in Q1 2014 and held it in 3 quarters. The position peaked at $461K in Q2 2014. 272 funds tracked by Wall St. Rank hold MYGN as of Q4 2014.

  • Index Management Solutions reported no remaining Myriad Genetics position as of Q4 2014 after selling out during the quarter.
  • Index Management Solutions sold 8,718 Myriad Genetics shares in Q4 2014, an estimated $336K.
  • Index Management Solutions first reported a position in Myriad Genetics in Q1 2014 and held it in 3 quarters.
  • Index Management Solutions's Myriad Genetics position peaked at $461K in Q2 2014.
  • 272 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2014.

Based on Index Management Solutions's 13F filing for Q4 2014, filed 13 Feb 2015.